BALTIMORE, Dec. 9 /PRNewswire/ -- XLHealth Chairman and CEO Patrick Hervy announced today that the Department of Health and Human Services, Centers for Medicare & Medicaid Services has selected the firm to provide disease management services in Tennessee. This is the firm’s second contract emphasizing the use of disease management to prevent the progression of chronic disease.
XLHealth’s contract is for the Voluntary Chronic Care Improvement program (CCIP), a major new initiative to help improve the quality of care for chronically ill beneficiaries under Medicare fee for service. XLHealth will be responsible for recruiting and offering disease management services to Medicare fee-for-service beneficiaries in Tennessee with diabetes, congestive heart failure and all related co-morbidities.
XLHealth is currently conducting a Medicare disease management demonstration program in Texas with 10,000 active patients. The firm finished the recruitment process in nine months and is in the early stages of the clinical phase of the project.
This CMS award is the latest in a series of significant new contracts and increasing numbers of covered individuals that XLHealth has added in the past year. The firm has more than doubled the number of its employees and is generating a more than 10-fold increase in revenues during the last 12-month period.
Success in the CCI program is defined as improvement in clinical quality of care, beneficiary satisfaction, and the achievement of savings targets. XLHealth’s track record illustrates results that will meet or exceed goals in all of these categories. The firm was originally founded on the principle of prediction and prevention of the complications of chronic illness. Said Paul Serini, XLHealth’s executive vice president, “The expertise associated with that approach will be advantageous with this program.”
About XLHealth
XLHealth (http://www.xlhealth.com/) has been at the forefront of disease management innovations since its inception. Founded by physicians, many of whom were affiliated with Johns Hopkins, XLHealth replaces the more customary remote telephone “call-center” or direct mail support with ongoing, face-to- face meetings with patients and physicians. XLHealth also uses tight coordination of care, behavior modification, and in-depth patient profiling integrated with claims, pharmacy, and lab information to generate sophisticated, predictive modeling. The firm emphasizes preventing avoidable and expensive disease complications and hospitalizations. XLHealth was recently awarded the Disease Management Association of America’s (DMAA) “Best Disease Management Program: Medicare.”
XLHealth
CONTACT: Amy Levy of Levy PR, Inc., +1-301-656-6212, or +1-202-686-3902,or fax: +1-301-656-6232, for XLHealth
Web site: http://www.xlhealth.com/